Intellia Therapeutics: Is $400 Million Worth the Cost?
Intellia Therapeutics is on the brink of a major transformation with funding of up to $400 million. But will this cost b...
Intellia Therapeutics is on the brink of a major transformation with funding of up to $400 million. But will this cost b...
Buying a mortgage rate buydown option can be a smart way to reduce your monthly costs. But is it really worth it?
Brady Corp, with an EPS forecast between 6.25 and 6.75, is examining the potential impacts of the low-margin IPS segment...
Arcosa shareholders voted in favor of an $8.5 billion deal with CRH. This move could pave the way for closing the agreem...
Stanley Black & Decker has agreed to sell Excel Industries. Could this decision help improve the returns of this industr...
Palo Alto Networks reported a remarkable 63% growth in its annual revenues in its latest report, but it also faced a net...
Celanese Corporation is reducing its stake in Nutrinova to 11% by selling 19% of its shares for $152 million. Is this mo...
The new Wolverine game from Insomniac is highly anticipated. Will PlayStation succeed with this big risk?
Qualcomm has become one of the main competitors in the tech industry by signing a major contract with Amazon. This deal...
Adobe is approaching its earnings announcement with a new outlook. Predictions about ADBE indicate exciting developments...
The United Arab Emirates had warned Netanyahu a few days before Hamas's attack on Israel. This news has significantly in...
The rise in crude oil prices has impacted the global energy market due to concerns over the continuation of military ten...